A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
for Chronic Myeloid Leukemia
4 locations incl. New York
Sponsor: Enliven Therapeutics
Sex: All·Age: 18+
Code: NCT05304377·Phase 1·Recruiting·Listed Mar 2022
Knight Cardiovascular Institute
Clinical research site in Portland, Oregon · 2222 NW LOVEJOY ST, #606, PORTLAND, OR 97210-3033 · (503) 229-7554 · Website
As of July 2026, 1 paid clinical trial is recruiting at Knight Cardiovascular Institute in Portland, Oregon. Active studies at this site cover conditions such as Chronic Myeloid Leukemia, Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive and Cml. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Knight Cardiovascular Institute (1)
More research sites in Portland
- Oregon Health and Science University (201 trials)
- Oregon Health & Science University (161 trials)
- Providence Portland Medical Center (117 trials)
- Providence Saint Vincent Medical Center (90 trials)
- OHSU Knight Cancer Institute (46 trials)
- Providence St. Vincent Medical Center (24 trials)
- VA Portland Health Care System, Portland, OR (22 trials)
- Legacy Emanuel Children's Hospital (19 trials)
- Oregon Health Sciences University (19 trials)
- Oregon Health & Science University (OHSU) (19 trials)
Explore more
Paid clinical trials in Portland, OR · Oregon clinical trials